Q1 2025 Earnings Call Transcript May 7, 2025 EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.65 EPS, expectations were $-0.65. Operator: Good morning. My ...

Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) ...

In advanced dry age-related macular degeneration (AMD ... significant protection of photoreceptors as measured by optical coherence tomography (OCT) and supported by slowing of loss of retinal ...

The exclusion criteria comprised: (1) severe cataracts or uncooperative status affecting examination quality; (2) concurrent fundus pathologies, including glaucoma, age-related macular degeneration ..

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Topcon Healthcare acquired RetInSight, an Austria-based company that develops AI-driven software for eye care professionals, ...